Department of Health

• Correspondence between the Minister for Health and pharmaceutical companies or industry representative groups on the General Pharmaceutical Legislation, between 1st August 2024 and 3rd January 2025. • Correspondence (sent and received including attachments) between Novo Nordisk and the Minister for Health, as well as minutes of meetings between same, and briefings prepared for those meetings, between 1st August 2024 and 3rd January 2025.